|
|||||
|
|
Residual risk of transfusion-transmitted hepatitis B virus (TT-HBV) infection by NAT-screened blood components: A review of observed versus modeled infectivity from donors with window period and occult HBV infections |
|
| Authors: | Nico Lelie Michael Busch Steve Kleinman |
| Affiliation: | 1. Lelie Research, Alkmaar, The Netherlands;2. Vitalant Research Institute, San Francisco, California, USA;3. University of British Columbia, Victoria, Canada |
| Abstract: | |
| Keywords: | infectious disease testing transfusion-transmitted disease hepatitis |